ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity.

Franziska Baatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.